title: Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancer.
authors.forename: Krishna S
authors.initials: KS
authors.lastname: Gunturu
authors.forename: Maysa
authors.initials: M
authors.lastname: Abu-Khalaf
authors.forename: Muhammad Wasif
authors.initials: MW
authors.lastname: Saif
mesh_terms: D000230:Adenocarcinoma / Q000150:complications* / Q000188:drug therapy; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000069347:Erlotinib Hydrochloride; D017809:Fatal Outcome; D006530:Hepatorenal Syndrome / Q000139:chemically induced*; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced*; D008297:Male; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000188:drug therapy; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride